Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bedside stomach scan could cut a deadly intubation risk

NCT ID NCT07823413

Prevention Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Emergency intubation can cause stomach contents to enter the lungs, a dangerous complication called aspiration. Researchers at Assiut University Hospital are testing whether adding a bedside gastric ultrasound scan to standard airway care lowers that risk. The trial enrolls 134 adults with trauma who need urgent intubation. Half receive the scan-guided bundle, and half receive usual care, and the team compares how often aspiration occurs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a bedside gastric ultrasound scan used to guide emergency airway management
What this could lead to
If it works, this could give emergency teams a simple, low-cost way to check stomach contents before intubation and reduce aspiration-related lung injury.
What could go wrong
The trial is small and single-center, so results may not apply everywhere. Ultrasound images can be hard to obtain in trauma patients, and the scan itself may not change outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 134 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * aged ≥ 18 years, presenting to the ED with a trauma-related indication and requiring urgent or semi-urgent endotracheal intubation, as determined by the treating emergency physician. Exclusion Criteria: * ● Allergy to local anesthetics, muscle relaxants, sedatives or dexmedetomidine. * History suggestive of intestinal obstruction or gastric outlet obstruction. * Known pregnancy. * Morbid obesity. * History of gastric/esophageal surgery. * Gastroesophageal reflux disease (GERD), or any other pathology affecting the physiology or function of the gastrointestinal tract or the lower esophageal sphincter (LES). * Patients in cardiac or respiratory arrest or any patients requiring crash intubation. * Patients with a gastric or duodenal tube in situ. * Anticipated difficult airway for reasons unrelated to aspiration risk (e.g., known airway tumor), where bundle elements would be superseded by a dedicated difficult-airway protocol. * Patients with vertebral and spinal trauma. * Clinically evident aspiration prior to gastric ultrasound assessment (e.g., witnessed aspiration before ED arrival). * Anticipated interval between the gastric ultrasound scan and induction exceeding 30 minutes, where a significant change in gastric content cannot be excluded. * Patients/guardians not consenting to take part in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aspiration are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aspiration

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.